What were the demographics of mRNA vaccine trial participants? What races/ethnicities were included?

For the Pfizer-BioNTech vaccine (37,586 participants in safety population):

  • Race/Ethnicity
    • 83.1% White (31,230)
    • 28.0% Hispanic/Latinx (10,522)
    • 9.1% Black (3,416)
    • 4.3% Asian (1,606)
    • 0.5% American Indian or Alaska Native (198)
    • 0.2% Native Hawaiian or other Pacific Islander (76) o
    • 2.3% Multiracial (853)
  • Gender
    • 50.6% Male (19,001)
    • 49.4% Female (18,585)
  • Age
    • Mean age 50.4 years

For the Moderna vaccine (30,350 participants in safety population):

  • Race/Ethnicity
    • 79.2% White (24,023)
    • 20.5% Hispanic/Latinx (6,234)
    • 10.2% Black (3,090)
    • 4.6% Asian (1,385)
    • 0.8% American Indian or Alaska Native (230)
    • 0.2% Native Hawaiian or other Pacific Islander (66) o 2.1% Multiracial (634)
    • 2.1% Other (636)
  • Gender
    • 52.7% Male (14,355)
    • 43.3% Female (13,175)
  • Age
    • Mean age 51.4 years
    • 24.8% 65 years and older (7,520)

For the Johnson & Johnson vaccine (43,783 participants globally):

  • Race/Ethnicity
    • 58.7% White
    • 45.3% Hispanic/Latinx
    • 19.4% Black
    • 3.3% Asian
    • 9.5% American Indian/Alaska Native
    • 0.2% Native Hawaiian or other Pacific Islander
    • 5.6% Multiracial
    • 1.4% Unknown
  • Gender
    • 55% Male
    • 45% Female
  • Age
    • Mean age 52 years
    • 34% 60 years and older (14,672)

Sources

Updated: March 1, 2021

ICSI

ICSI